Dihydroethanoanthracene Derivatives as In Vitro Malarial Chloroquine Resistance Reversal Agents-Reference-Cited by-同舟云学术

Dihydroethanoanthracene Derivatives as In Vitro Malarial Chloroquine Resistance Reversal Agents

Published:2004-07 Issue:7 Volume:48 Page:2753-2756
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Millet Julie¹²,Torrentino-Madamet Marylin¹²,Alibert Sandrine³²,Rogier Christophe¹²,Santelli-Rouvier Christiane³²,Mosnier Joel¹²,Baret Eric¹²,Barbe Jacques³²,Parzy Daniel¹²,Pradines Bruno¹²

Affiliation:

1. Unité de Parasitologie, Institut de Médecine Tropicale du Service de Santé des Armées

2. Institut Fédératif de la Recherche 48, Marseille, France

3. GERCTOP-UMR CNRS 6009, Faculté de Pharmacie

Abstract

ABSTRACT The ability of four 9,10-dihydroethanoanthracene derivatives (BG920, BG932, BG958, and BG996), as well as verapamil and promethazine, to reverse chloroquine resistance was assessed against 24 chloroquine-resistant and 10 chloroquine-susceptible strains of Plasmodium falciparum from different countries. The 9,10-dihydroethanoanthracene derivatives clearly increase chloroquine susceptibility only in chloroquine-resistant isolates.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.48.7.2753-2756.2004

Reference29 articles.

1. Adovelande, J., J. Deleze, and J. Schrevel. 1998. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum. Biochem. Pharmacol.55:433-440.

2. Alibert, S., C. Santelli-Rouvier, B. Pradines, C. Houdoin, D. Parzy, J. Karolak-Wojciechowska, and J. Barbe. 2002. Synthesis and effects on chloroquine susceptibility in Plasmodium falciparum of a series of new dihydroanthracene derivatives. J. Med. Chem.45:3195-3209.

3. Alibert-Franco, S., C. Santelli-Rouvier, J. Barbe, B. Pradines, C. Houdoin, and D. Parzy. 1999. 9,10-(3′,4′-pyrrolidino)-9,10-dihydroanthracene and structurally related compounds as synergistic antimalarial drugs. Heterocyclic Comm.5:235-240.

4. Barnes, A. J., E. L. Ong, E. M. Dunbar, B. K. Mandal, and E. G. L. Wilkins. 1991. Failure of chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet338:1338-1339.

5. Basco, L. K., P. Ringwald, and J. Le Bras. 1991. Chloroquine potentiating action of antihistaminics in Plasmodium falciparum in vitro. Ann. Trop. Med. Parasitol.85:223-228.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DRUG RESISTANCE AND RESISTANCE REVERSAL STRATEGIES IN MALARIA PARASITE;Journal of microbiology, biotechnology and food sciences;2024-02-05

2. Design, synthesis, and in silico-in vitro antimalarial evaluation of 1,2,3-triazole-linked dihydropyrimidinone quinoline hybrids;Structural Chemistry;2023-02-27

3. Microwave-assisted regioselective synthesis of substituted-9-bromo-9,10-dihydro-9,10-ethanoanthracenes via Diels-Alder cycloaddition;Journal of King Saud University - Science;2020-12

4. Synthesis and Antimicrobial Activity of Some Novel bis Polyfunctional Pyridine, Pyran, and Thiazole Derivatives;Journal of Heterocyclic Chemistry;2018-08-13

5. Overview on the synthetic routes to nicotine nitriles;Synthetic Communications;2018-01-23